SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19

ConclusionSerological immune responses after COVID-19 show considerable inter-individual variability, but show an association with increasing age and higher severity of disease. IgG-type anti-SARS-CoV-2 antibodies remain positive in 90% of the individuals 30  weeks after onset of symptoms.
Source: Infection - Category: Infectious Diseases Source Type: research